Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The frequent exacerbator phenotype in bronchiectasis revisited: Data from EMBARC registry.

American journal of respiratory and critical care medicine·2026
Same author

Airway clearance management for bronchiectasis in China: a multicentre cross-sectional study from the Chinese bronchiectasis registry (BE-China).

The Lancet regional health. Western Pacific·2026
Same author

Comorbid diabetes disease severity and microbial changes in patients with bronchiectasis: a combined analysis of data from the EMBARC, EMBARC-India, Australian, and BE-China registries.

The Lancet. Respiratory medicine·2026
Same author

Nasal nitric oxide combined with clinical features for preliminary screening of primary ciliary dyskinesia in bronchiectasis.

The European respiratory journal·2026
Same author

Multi-omics profiling of fungal balls in chronic pulmonary aspergillosis patients reveals microbiome dynamics and metabolic adaptations.

mBio·2026
Same author

Advances in understanding respiratory microbiome are reshaping the management of respiratory diseases.

American journal of respiratory and critical care medicine·2026

Related Experiment Video

Updated: May 30, 2026

Subconjunctival Administration of Adeno-associated Virus Vectors in Small Animal Models
06:16

Subconjunctival Administration of Adeno-associated Virus Vectors in Small Animal Models

Published on: March 16, 2022

Novel interventional approaches for ALI/ARDS: cell-based gene therapy.

Ying-Gang Zhu1, Jie-Ming Qu, Jing Zhang

  • 1Department of Pulmonary Medicine, Huadong Hospital, Shanghai 200040, China.

Mediators of Inflammation
|July 26, 2011
PubMed
Summary

New cell and gene therapies show promise for treating acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). Combining these approaches may offer an innovative strategy for preventing and managing these critical lung conditions.

More Related Videos

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
06:48

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

Related Experiment Videos

Last Updated: May 30, 2026

Subconjunctival Administration of Adeno-associated Virus Vectors in Small Animal Models
06:16

Subconjunctival Administration of Adeno-associated Virus Vectors in Small Animal Models

Published on: March 16, 2022

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
06:48

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

Area of Science:

  • Regenerative Medicine
  • Genomics
  • Critical Care Medicine

Background:

  • Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are significant causes of death in critically ill patients.
  • Current treatments for ALI/ARDS, including supportive care and mechanical ventilation, have limitations and are often controversial.
  • There is a need for novel therapeutic strategies to improve outcomes for patients with ALI/ARDS.

Purpose of the Study:

  • To explore the potential of stem cell therapy and genomics therapy for treating ALI/ARDS.
  • To investigate the combined benefits of cell and gene therapy for ALI/ARDS.
  • To establish a basis for innovative therapeutic approaches for ALI/ARDS.

Main Methods:

  • Review of current scientific literature on stem cell therapy for ALI/ARDS.
  • Analysis of genomics therapy approaches for modulating inflammatory responses in ALI/ARDS.
  • Evaluation of preclinical and clinical data on combined cell and gene therapy strategies.

Main Results:

  • Stem cells possess self-renewing and differentiating capabilities, making them suitable for regenerative approaches.
  • Genomics therapy can upregulate anti-inflammatory mediators, potentially mitigating lung injury.
  • Combined cell and gene therapy has demonstrated additive benefits in preclinical models, suggesting enhanced efficacy.

Conclusions:

  • Combined cell and gene therapy represents a promising innovative strategy for the prevention and treatment of ALI/ARDS.
  • This combined approach offers a new therapeutic avenue beyond conventional treatments for critical lung conditions.
  • Further research and development are warranted to translate these findings into clinical practice for ALI/ARDS patients.